EcoDrugPlus

Atrial Natriuretic Peptide Receptor 2-Like

Ensembl ID : ENSHBUG00000011755
Gene Symbol: LOC102310518
2 Cross references
185 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSHBUG00000008994
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:

Aurora Kinase B-Like

Ensembl ID : ENSHBUG00000006934
Gene Symbol: LOC102291667
3 Cross references
205 Possible Orthologues:

Bcl-2-Like Protein 1

Ensembl ID : ENSHBUG00000013989
Gene Symbol: LOC102311729
2 Cross references
219 Possible Orthologues:

Beta-1 Adrenergic Receptor-Like

Ensembl ID : ENSHBUG00000012536
Gene Symbol: LOC102302818
3 Cross references
196 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSHBUG00000003812
Gene Symbol: LOC102294801
3 Cross references
195 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSHBUG00000022886
Gene Symbol: BACE1
3 Cross references
218 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSHBUG00000009085
Gene Symbol: BDKRB2
3 Cross references
223 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSHBUG00000009040
Gene Symbol: BDKRB2
4 Cross references
167 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSHBUG00000009045
Gene Symbol: BDKRB2
2 Cross references
146 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSHBUG00000018086
Gene Symbol: BDKRB2
3 Cross references
229 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSHBUG00000018073
Gene Symbol: BDKRB2
1 Cross references
225 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).